IGC Pharma (IGC) Interest Coverage Ratio Growth (3y) (2013 - 2017)
IGC Pharma (IGC) Interest Coverage Ratio Growth (3y) (2013 - 2017) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
IGC Pharma |
27.49 Mn |
27.22 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2017 |
1.01% |
| Sep 30, 2017 |
12.44% |
| Jun 30, 2017 |
22.08% |
| Mar 31, 2017 |
31.72% |
| Dec 31, 2016 |
-14.06% |
| Sep 30, 2016 |
-19.36% |
| Jun 30, 2016 |
-46.87% |
| Mar 31, 2016 |
41.32% |
| Dec 31, 2015 |
-26.88% |
| Sep 30, 2015 |
29.87% |
| Jun 30, 2015 |
39.09% |
| Mar 31, 2015 |
185.60% |
| Dec 31, 2014 |
-10.21% |
| Sep 30, 2014 |
-25.72% |
| Jun 30, 2014 |
-100.79% |
| Mar 31, 2014 |
-11.19% |
| Dec 31, 2013 |
-4.96% |
| Sep 30, 2013 |
-16.01% |
| Jun 30, 2013 |
2.36% |
